@inproceedings{2955103,
    title = "Ibrutinib treatment in Waldenstrom's macroglobulinemia (WM): follow-up results of the phase 3 iNNOVATE (TM) study",
    author = "Buske, C and Tedeschi, A and Trotman, J and Garcia-Sanz, R and Macdonald, D and Leblond, V and Mahe, B and Herbaux, C and Tam, CS and Palomba, ML and others",
    year = "2019",
    pages = "158--158",
    booktitle = "ONCOLOGY RESEARCH AND TREATMENT"
}